Any thouhgts on Cubist Pharmasuiticals (CBST)?
Started Apr 16 2009 at 4:11AM (EST) (By miller)
I have heard of Cubist, that their drug is very effective and orders are piling up..
Cubist Pharmaceuticals market an "antibiotic" mist, that is sprayed into the air in hospitals. This antibiotic is very successful in reducing the amount of infections people catch when visiting hospitals.
It's hard to believe how dangerous simply walking into a hospital is these days. They are living germ beds!
MikeHavRx,
You're the top man on these issues, Do you have an Opinion on CBST?
Thanks
MM
Cubist Pharmaceuticals market an "antibiotic" mist, that is sprayed into the air in hospitals. This antibiotic is very successful in reducing the amount of infections people catch when visiting hospitals.
It's hard to believe how dangerous simply walking into a hospital is these days. They are living germ beds!
MikeHavRx,
You're the top man on these issues, Do you have an Opinion on CBST?
Thanks
MM
This post is more than 60 days old. Replying to it might be confusing for other members reading the discussion.
By all means, keep the ball rolling and post a new opinion.
- Advertisement -
4 Comments
Top 98%
VirtualMan
Apr 16 2009 at 5:06AM (EST)
Looks like a long shot to me.
Top 1%
MikeHavRx
Apr 16 2009 at 8:55AM (EST)
CBST looks like a buy on the recent pullback to mid-teens (15-16) after the spike in early April on rumor that NVS is insterested in acquiring the company for $1.6B. CBST is currently trading at a $1B market cap at 17 bucks with an enterprise value around $900M so at the very least you can expect more rumors to circulate in the future given all the M&A activity in bio-pharma and if an actual deal goes through should be in the mid-20s (24-26).
Top 1%
DowJonesDave
Apr 16 2009 at 10:26AM (EST)
I don't like the chart for short term long. I'm just giving my opinion by invite. I don't follow the stock and didn't look at anything but the chart.
Top 43%
DividendTree
Apr 16 2009 at 10:21PM (EST)
CBST does not pay dividends. It does not have +ve free cash flow. Therefore, it does not fit into my investing principles. I will pass.